Generate Biomedicines, Inc. (GENB) Live Share Price, Invest From India

Generate Biomedicines, Inc. Stock Performance

as on September 26, 2026 at 2:15 pm IST

Day's Low
Day's High
$15.03
Day's Price Range
$16.09
$15.15
0.79%
Downside
6.20%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$15.15
100.00%
Downside
-100.00%
Upside

Generate Biomedicines, Inc. share price movements today

Previous Close: $15.99
Open: $16.09
Volume: 1.5M
Market Cap: $2.1B
Day's Low - High: $15.03 - $16.09

Generate Biomedicines, Inc. Historical Returns

1 Month Return: -6.13 %
3 Month Return: -8.01 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Generate Biomedicines, Inc. Stock Fundamentals & Key Indicators

Check Generate Biomedicines, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

-1.06

Dividend Yield

0.00%

PE Ratio (TTM)

-15.08

Industry PE ratio

-12.76

PEG Ratio

-0.15084905660377357

Return On Equity TTM

-108.80%

Generate Biomedicines, Inc. Stock Valuation

Track how Generate Biomedicines, Inc. P/E has moved over time to understand its valuation trends.

Generate Biomedicines, Inc. in the last 2 years

Overview
Trends

Lowest (-7.53x)

December 31, 2024

Industry (-12.76x)

December 31, 2025

Today (-2.54x)

December 31, 2025

Highest (-2.54x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -2.54x

Generate Biomedicines, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Generate Biomedicines, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Generate Biomedicines, Inc.	StrongBuy	$2.1B	NA	-15.08	75.82%	0.00%
Moderna	Neutral	$77.8B	-53.76%	-24.41	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$132.4B	186.58%	30.16	86.04%	0.00%
Regeneron	Buy	$82.8B	23.34%	19.01	84.86%	0.46%

Analyst Recommendation on Generate Biomedicines, Inc. Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Generate Biomedicines, Inc.. Average target price of $25.3333333333333

Indian Investors' Interest in Generate Biomedicines, Inc. Stock

Search interest for Generate Biomedicines, Inc. Stock has increased by 196% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 27, 2026 to September 26, 2026

Change:196% versus previous 30 day period

Generate Biomedicines, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2026	Jun 2026
Total Revenue	7	6
Gross Profit	3	6
Operating Income	-64	-71
EBITDA	-60	-63
Interest Expense	0	0
Depreciation	3	3
Income Before Tax	-61	-67
Income Tax Expense	0	0
Net Income	-61	-67
Net Profit Margin	54.69%	100.00%

Generate Biomedicines, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2024	Dec 2025
Total Revenue	20	31
Gross Profit	20	31
Operating Income	-196	-235
EBITDA	-163	-208
Interest Expense	2	1
Depreciation	15	13
Income Before Tax	-181	-222
Income Tax Expense	0	0
Net Income	-173	-203
Net Profit Margin	100.00%	100.00%

Generate Biomedicines, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2026	Jun 2026
Net Income	-61	-67
Operating Cash Flow	-80	-57
Investing Cash Flow	-252	33
Financing Cash Flow	371	0
Change in Cash	160	-25

Generate Biomedicines, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2024	Dec 2025
Net Income	-181	-222
Operating Cash Flow	-117	-200
Investing Cash Flow	-57	116
Financing Cash Flow	91	28
Change in Cash	-84	-55

Mutual Funds that own Generate Biomedicines, Inc. Stock

Check out the Mutual Funds with significant holdings in Generate Biomedicines, Inc..

Funds	Holdings	Shares Held
Federated Hermes Income Securities Trust	0.006622%	8500

Global Institutional Holdings in Generate Biomedicines, Inc.

Funds	Holdings
Noubar Afeyan	48.83%
John Toomey, Jr.	1.34%
ARK	1.33%
Felix Baker	1.11%
Vanguard	1%

See all

Insights on Generate Biomedicines, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, GENB stock has moved down by -11.6%

About Generate Biomedicines, Inc.

Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities. The company's pipeline includes several key candidates: GB-0895, an investigational long-acting anti-TSLP monoclonal antibody designed for bi-annual dosing in severe asthma; GB-4362, an MMAE payload neutralizer monoclonal antibody; and GB-5267, a MUC16 CAR-T cell therapy. Integral to their work is the Generate Platform, a sophisticated system engineered to be versatile across diverse therapeutic areas and protein modalities. This platform combines computational innovation with scalable biohardware, allowing them to tackle therapeutic hurdles beyond the capabilities of traditional technologies. Established in 2018, the company was initially known as Generate Biologics, Inc. before rebranding to Generate Biomedicines, Inc. in February 2020. Its headquarters are located in Somerville, Massachusetts.

Organisation	Generate Biomedicines, Inc.
Headquarters	101 South Street, Somerville, MA, 02143, US
Industry	Biotechnology
CEO	Michael T. Nally
E-voting on shares	Click here to vote

Key Management of Generate Biomedicines, Inc.

Name	Title
Dr. Noubar B. Afeyan Ph.D.	Co-founder & Independent Chair of the Board
Dr. Aarif Khakoo M.B.A., M.D.	Chief Scientific Officer
Mr. Sean B. W. Martin J.D.	Secretary, Chief Legal Officer & General Counsel
Dr. Daria Hazuda Ph.D.	Senior Vice President of Discovery Strategy
Ms. Beth Grous	Chief People Officer
Mr. Sahm Nasseri M.B.A.	Senior Vice President of Business Development & Strategy
Mr. Michael T. Nally M.B.A.	CEO & Director
Dr. Jason E. Silvers J.D., M.D.	President & CFO
Dr. Gevorg Grigoryan Ph.D.	Co-Founder & CTO
Ms. Molly Gibson Ph.D.	Co-Founder

FAQs

What is Generate Biomedicines, Inc. share price today?

Generate Biomedicines, Inc. share price today is $15.15 as on September 26, 2026 at 8:45 am IST at the close of the market. Generate Biomedicines, Inc. share today touched a day high of $16.09 and a low of $15.03.

What is the 52 week high and 52 week low for Generate Biomedicines, Inc. share?

Generate Biomedicines, Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Generate Biomedicines, Inc. stock price today i.e. September 26, 2026 at 8:45 am IST is closed at $15.15,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Generate Biomedicines, Inc.'s market capitalisation today?

Generate Biomedicines, Inc. market capitalisation is $0.00T as on September 26, 2026 at 8:45 am IST.

How to invest in Generate Biomedicines, Inc. Stock (GENB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Generate Biomedicines, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Generate Biomedicines, Inc. Shares that will get you 0.0990 shares as per Generate Biomedicines, Inc. share price of $15.15 per share as on September 26, 2026 at 8:45 am IST.

What is the minimum amount required to buy Generate Biomedicines, Inc. Stock (GENB) from India?

Indian investors can start investing in Generate Biomedicines, Inc. (GENB) shares with as little as ₹95.8125 or $1 (as of September 26, 2026 at 12:45 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹958.13 in Generate Biomedicines, Inc. stock (as per the Rupee-Dollar exchange rate as on September 26, 2026 at 12:45 pm IST). Based on Generate Biomedicines, Inc. share’s latest price of $15.15 as on September 26, 2026 at 8:45 am IST, you will get 0.6601 shares of Generate Biomedicines, Inc.. Learn more about fractional shares .